Caris Life Sciences announced that Indiana University Melvin and Bren Simon Comprehensive Cancer Center has joined the Caris Precision Oncology Alliance™ (POA). The POA is a growing network of cancer centers that collaborate to advance oncology and biomarker research.
Established in 1992, the IU Simon Comprehensive Cancer Center is Indiana's sole National Cancer Institute (NCI)-designated comprehensive cancer center. It conducts all phases of cancer research, from laboratory studies to clinical trials to population-based studies.
Read more about the POA here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.